Vascular complications of diabetes: current issues in pathogenesis and treatment
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Malden, Mass.
Blackwell Pub.
2005
|
| Ausgabe: | 2nd ed |
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | vi, 234 p. |
| ISBN: | 9781405127851 1405127856 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044130198 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2005 |||| o||u| ||||||eng d | ||
| 020 | |a 9781405127851 |c alk. paper |9 978-1-4051-2785-1 | ||
| 020 | |a 1405127856 |c alk. paper |9 1-4051-2785-6 | ||
| 035 | |a (ZDB-30-PAD)EBC351646 | ||
| 035 | |a (ZDB-89-EBL)EBL351646 | ||
| 035 | |a (OCoLC)476173140 | ||
| 035 | |a (DE-599)BVBBV044130198 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 616.1/3 |2 22 | |
| 245 | 1 | 0 | |a Vascular complications of diabetes |b current issues in pathogenesis and treatment |c editor, Richard Donnelly ; associate editor, Edward Horton |
| 250 | |a 2nd ed | ||
| 264 | 1 | |a Malden, Mass. |b Blackwell Pub. |c 2005 | |
| 300 | |a vi, 234 p. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 505 | 0 | |a The public health impact of the diabetes epidemic -- Risk factors -- Diabetic nephropathy -- Coronary heart disease and diabetes -- Diabetes and cerebrovascular disease -- Erectile dysfunction -- Evidence-based interventions to prevent or retard vascular complications -- Classification and clinical features of neuropathy -- Pathophsiology [sic] of diabetic neuropathy -- Epidemiology and natural history of DPN -- Detections/screenings/assessment -- Foot ulceration and charcot arthropathy -- Treatment options -- Management guidelines for diabetic peripheral neuropathy and foot ulceration -- Diabetic retinopathy: epidemiology and risk factors -- Classification and diagnosis of diabetic retinopathy -- Diabetic maculopathy -- Proliferative diabetic retinopathy -- Non-retinal diabetic ocular complications -- Pathophysiology & potential targets for therapeutic intervention -- Protein kinase C -- PKC activation & vascular permeability -- Role of PKC activation in cardiovascular and renal complications of diabetes -- Experimental pharmacology using isoform-selective PKC inhibitors -- Clinical trials with ruboxistaurin | |
| 650 | 4 | |a Diabetic angiopathies | |
| 700 | 1 | |a Donnelly, Richard |d 1960- |e Sonstige |4 oth | |
| 700 | 1 | |a Horton, Edward S. |e Sonstige |4 oth | |
| 912 | |a ZDB-30-PAD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029537043 | ||
Datensatz im Suchindex
| _version_ | 1804177218305261568 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV044130198 |
| collection | ZDB-30-PAD |
| contents | The public health impact of the diabetes epidemic -- Risk factors -- Diabetic nephropathy -- Coronary heart disease and diabetes -- Diabetes and cerebrovascular disease -- Erectile dysfunction -- Evidence-based interventions to prevent or retard vascular complications -- Classification and clinical features of neuropathy -- Pathophsiology [sic] of diabetic neuropathy -- Epidemiology and natural history of DPN -- Detections/screenings/assessment -- Foot ulceration and charcot arthropathy -- Treatment options -- Management guidelines for diabetic peripheral neuropathy and foot ulceration -- Diabetic retinopathy: epidemiology and risk factors -- Classification and diagnosis of diabetic retinopathy -- Diabetic maculopathy -- Proliferative diabetic retinopathy -- Non-retinal diabetic ocular complications -- Pathophysiology & potential targets for therapeutic intervention -- Protein kinase C -- PKC activation & vascular permeability -- Role of PKC activation in cardiovascular and renal complications of diabetes -- Experimental pharmacology using isoform-selective PKC inhibitors -- Clinical trials with ruboxistaurin |
| ctrlnum | (ZDB-30-PAD)EBC351646 (ZDB-89-EBL)EBL351646 (OCoLC)476173140 (DE-599)BVBBV044130198 |
| dewey-full | 616.1/3 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.1/3 |
| dewey-search | 616.1/3 |
| dewey-sort | 3616.1 13 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 2nd ed |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02301nmm a2200361zc 4500</leader><controlfield tag="001">BV044130198</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2005 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781405127851</subfield><subfield code="c">alk. paper</subfield><subfield code="9">978-1-4051-2785-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1405127856</subfield><subfield code="c">alk. paper</subfield><subfield code="9">1-4051-2785-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC351646</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL351646</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)476173140</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044130198</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/3</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vascular complications of diabetes</subfield><subfield code="b">current issues in pathogenesis and treatment</subfield><subfield code="c">editor, Richard Donnelly ; associate editor, Edward Horton</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2nd ed</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Malden, Mass.</subfield><subfield code="b">Blackwell Pub.</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">vi, 234 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">The public health impact of the diabetes epidemic -- Risk factors -- Diabetic nephropathy -- Coronary heart disease and diabetes -- Diabetes and cerebrovascular disease -- Erectile dysfunction -- Evidence-based interventions to prevent or retard vascular complications -- Classification and clinical features of neuropathy -- Pathophsiology [sic] of diabetic neuropathy -- Epidemiology and natural history of DPN -- Detections/screenings/assessment -- Foot ulceration and charcot arthropathy -- Treatment options -- Management guidelines for diabetic peripheral neuropathy and foot ulceration -- Diabetic retinopathy: epidemiology and risk factors -- Classification and diagnosis of diabetic retinopathy -- Diabetic maculopathy -- Proliferative diabetic retinopathy -- Non-retinal diabetic ocular complications -- Pathophysiology & potential targets for therapeutic intervention -- Protein kinase C -- PKC activation & vascular permeability -- Role of PKC activation in cardiovascular and renal complications of diabetes -- Experimental pharmacology using isoform-selective PKC inhibitors -- Clinical trials with ruboxistaurin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetic angiopathies</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Donnelly, Richard</subfield><subfield code="d">1960-</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Horton, Edward S.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029537043</subfield></datafield></record></collection> |
| id | DE-604.BV044130198 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:44:35Z |
| institution | BVB |
| isbn | 9781405127851 1405127856 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029537043 |
| oclc_num | 476173140 |
| open_access_boolean | |
| physical | vi, 234 p. |
| psigel | ZDB-30-PAD |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | Blackwell Pub. |
| record_format | marc |
| spelling | Vascular complications of diabetes current issues in pathogenesis and treatment editor, Richard Donnelly ; associate editor, Edward Horton 2nd ed Malden, Mass. Blackwell Pub. 2005 vi, 234 p. txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index The public health impact of the diabetes epidemic -- Risk factors -- Diabetic nephropathy -- Coronary heart disease and diabetes -- Diabetes and cerebrovascular disease -- Erectile dysfunction -- Evidence-based interventions to prevent or retard vascular complications -- Classification and clinical features of neuropathy -- Pathophsiology [sic] of diabetic neuropathy -- Epidemiology and natural history of DPN -- Detections/screenings/assessment -- Foot ulceration and charcot arthropathy -- Treatment options -- Management guidelines for diabetic peripheral neuropathy and foot ulceration -- Diabetic retinopathy: epidemiology and risk factors -- Classification and diagnosis of diabetic retinopathy -- Diabetic maculopathy -- Proliferative diabetic retinopathy -- Non-retinal diabetic ocular complications -- Pathophysiology & potential targets for therapeutic intervention -- Protein kinase C -- PKC activation & vascular permeability -- Role of PKC activation in cardiovascular and renal complications of diabetes -- Experimental pharmacology using isoform-selective PKC inhibitors -- Clinical trials with ruboxistaurin Diabetic angiopathies Donnelly, Richard 1960- Sonstige oth Horton, Edward S. Sonstige oth |
| spellingShingle | Vascular complications of diabetes current issues in pathogenesis and treatment The public health impact of the diabetes epidemic -- Risk factors -- Diabetic nephropathy -- Coronary heart disease and diabetes -- Diabetes and cerebrovascular disease -- Erectile dysfunction -- Evidence-based interventions to prevent or retard vascular complications -- Classification and clinical features of neuropathy -- Pathophsiology [sic] of diabetic neuropathy -- Epidemiology and natural history of DPN -- Detections/screenings/assessment -- Foot ulceration and charcot arthropathy -- Treatment options -- Management guidelines for diabetic peripheral neuropathy and foot ulceration -- Diabetic retinopathy: epidemiology and risk factors -- Classification and diagnosis of diabetic retinopathy -- Diabetic maculopathy -- Proliferative diabetic retinopathy -- Non-retinal diabetic ocular complications -- Pathophysiology & potential targets for therapeutic intervention -- Protein kinase C -- PKC activation & vascular permeability -- Role of PKC activation in cardiovascular and renal complications of diabetes -- Experimental pharmacology using isoform-selective PKC inhibitors -- Clinical trials with ruboxistaurin Diabetic angiopathies |
| title | Vascular complications of diabetes current issues in pathogenesis and treatment |
| title_auth | Vascular complications of diabetes current issues in pathogenesis and treatment |
| title_exact_search | Vascular complications of diabetes current issues in pathogenesis and treatment |
| title_full | Vascular complications of diabetes current issues in pathogenesis and treatment editor, Richard Donnelly ; associate editor, Edward Horton |
| title_fullStr | Vascular complications of diabetes current issues in pathogenesis and treatment editor, Richard Donnelly ; associate editor, Edward Horton |
| title_full_unstemmed | Vascular complications of diabetes current issues in pathogenesis and treatment editor, Richard Donnelly ; associate editor, Edward Horton |
| title_short | Vascular complications of diabetes |
| title_sort | vascular complications of diabetes current issues in pathogenesis and treatment |
| title_sub | current issues in pathogenesis and treatment |
| topic | Diabetic angiopathies |
| topic_facet | Diabetic angiopathies |
| work_keys_str_mv | AT donnellyrichard vascularcomplicationsofdiabetescurrentissuesinpathogenesisandtreatment AT hortonedwards vascularcomplicationsofdiabetescurrentissuesinpathogenesisandtreatment |